Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Clinical trial NCT04920838 · UNKNOWN

Trial details

NCT number: NCT04920838
Sponsor: ANRS, Emerging Infectious Diseases
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Covid19 Covid19 Drug Treatment Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV2 Infection

Start date: 2021-04-12
Primary completion: 2023-08-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.